Testing effectiveness (Phase 2)Study completedNCT03248531
What this trial is testing
Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
Who this might be right for
Hidradenitis Suppurativa
UCB Biopharma SRL 90